相似文献
1
Testosterone and Adult Male Bone: Actions Independent of 5α-Reductase and Aromatase.
Exerc Sport Sci Rev. 2015 Oct;43(4):222-30. doi: 10.1249/JES.0000000000000056.
2
Testosterone, not 5α-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells.
Mol Endocrinol. 2011 Apr;25(4):656-68. doi: 10.1210/me.2010-0367. Epub 2011 Jan 27.
3
Testosterone selectively affects aromatase and 5alpha-reductase activities in the green anole lizard brain.
Gen Comp Endocrinol. 2010 Mar 1;166(1):128-33. doi: 10.1016/j.ygcen.2009.11.006. Epub 2009 Nov 14.
4
Testosterone metabolism in the avian hypothalamus.
J Steroid Biochem Mol Biol. 1991;40(4-6):557-70. doi: 10.1016/0960-0760(91)90277-c.
5
Effects of perinatal exposure to bisphenol A on the intraprostatic levels of aromatase and 5α-reductase isozymes in juvenile rats.
Food Chem Toxicol. 2018 May;115:20-25. doi: 10.1016/j.fct.2018.02.060. Epub 2018 Feb 28.
6
Testosterone metabolites mediate its effects on myocardial damage induced by ischemia/reperfusion in male Wistar rats.
Steroids. 2013 Mar;78(3):362-9. doi: 10.1016/j.steroids.2012.12.004. Epub 2012 Dec 29.
7
Opposite effects of dihydrotestosterone and estradiol on apoptosis in the anterior pituitary gland from male rats.
Endocrine. 2016 Mar;51(3):506-16. doi: 10.1007/s12020-015-0719-2. Epub 2015 Aug 22.
8
Bone metabolism in men: role of aromatase activity.
J Endocrinol Invest. 2007;30(6 Suppl):18-23.
9
A 5α-reductase (SRD5A2) polymorphism is associated with serum testosterone and sex hormone-binding globulin in men, while aromatase (CYP19A1) polymorphisms are associated with oestradiol and luteinizing hormone reciprocally.
Clin Endocrinol (Oxf). 2019 Feb;90(2):301-311. doi: 10.1111/cen.13885. Epub 2018 Nov 19.
10
New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Biochimie. 2013 Nov;95(11):2097-106. doi: 10.1016/j.biochi.2013.07.023. Epub 2013 Aug 9.
引用本文的文献
1
Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury-a randomized, double-blind, and placebo-controlled pilot study.
Front Neurol. 2024 Dec 11;15:1479264. doi: 10.3389/fneur.2024.1479264. eCollection 2024.
2
Bodyweight influences the relationship between serum testosterone and bone mineral density in men with spinal cord injury.
Spinal Cord. 2024 Oct;62(10):555-561. doi: 10.1038/s41393-024-01022-4. Epub 2024 Jul 29.
3
New evidence for the effect of type 2 diabetes and glycemic traits on testosterone levels: a two-sample Mendelian randomization study.
Front Endocrinol (Lausanne). 2023 Oct 11;14:1238090. doi: 10.3389/fendo.2023.1238090. eCollection 2023.
4
Altered circulating GDF-15 level predicts sex hormone imbalance in males with major depressive disorder.
BMC Psychiatry. 2023 Jan 12;23(1):28. doi: 10.1186/s12888-023-04527-z.
5
Associations Between Tenascin-C and Testosterone Deficiency in Men with Major Depressive Disorder: A Cross-Sectional Retrospective Study.
J Inflamm Res. 2021 Mar 16;14:897-905. doi: 10.2147/JIR.S298270. eCollection 2021.
6
Locomotor training with adjuvant testosterone preserves cancellous bone and promotes muscle plasticity in male rats after severe spinal cord injury.
J Neurosci Res. 2020 May;98(5):843-868. doi: 10.1002/jnr.24564. Epub 2019 Dec 4.
7
Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study.
Front Pharmacol. 2019 Mar 15;10:173. doi: 10.3389/fphar.2019.00173. eCollection 2019.
8
Longitudinal Examination of Bone Loss in Male Rats After Moderate-Severe Contusion Spinal Cord Injury.
Calcif Tissue Int. 2019 Jan;104(1):79-91. doi: 10.1007/s00223-018-0471-8. Epub 2018 Sep 14.
9
Activity-Based Physical Rehabilitation with Adjuvant Testosterone to Promote Neuromuscular Recovery after Spinal Cord Injury.
Int J Mol Sci. 2018 Jun 7;19(6):1701. doi: 10.3390/ijms19061701.
10
Dihydrotestosterone, a robust promoter of osteoblastic proliferation and differentiation: understanding of time-mannered and dose-dependent control of bone forming cells.
Iran J Basic Med Sci. 2017 Aug;20(8):894-904. doi: 10.22038/IJBMS.2017.9111.
本文引用的文献
1
Sex steroid actions in male bone.
Endocr Rev. 2014 Dec;35(6):906-60. doi: 10.1210/er.2014-1024. Epub 2014 Sep 9.
2
Influence of aromatase inhibition on the bone-protective effects of testosterone.
J Bone Miner Res. 2014 Nov;29(11):2405-13. doi: 10.1002/jbmr.2265.
3
Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.
Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E433-42. doi: 10.1152/ajpendo.00592.2013. Epub 2013 Dec 10.
4
The association of α-blockers and 5-α reductase inhibitors in benign prostatic hyperplasia with fractures.
Am J Med Sci. 2014 Jun;347(6):463-71. doi: 10.1097/MAJ.0b013e3182a2169c.
5
The role of estrogen and androgen receptors in bone health and disease.
Nat Rev Endocrinol. 2013 Dec;9(12):699-712. doi: 10.1038/nrendo.2013.179. Epub 2013 Sep 17.
6
Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials.
J Clin Endocrinol Metab. 2013 Sep;98(9):3615-26. doi: 10.1210/jc.2013-1358. Epub 2013 Jul 3.
7
Assessment of steroidogenesis and steroidogenic enzyme functions.
J Steroid Biochem Mol Biol. 2013 Sep;137:176-82. doi: 10.1016/j.jsbmb.2013.05.017. Epub 2013 Jun 13.
8
17β-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) preserves bone mineral density in skeletally mature orchiectomized rats without prostate enlargement.
Bone. 2012 Oct;51(4):667-73. doi: 10.1016/j.bone.2012.07.008. Epub 2012 Jul 24.
9
Intracrine and myotrophic roles of 5α-reductase and androgens: a review.
Med Sci Sports Exerc. 2012 May;44(5):818-26. doi: 10.1249/MSS.0b013e31823bfcbf.
10
Reduced bone mass and muscle strength in male 5α-reductase type 1 inactivated mice.
PLoS One. 2011;6(6):e21402. doi: 10.1371/journal.pone.0021402. Epub 2011 Jun 22.
Zotero 插件